- Country: Italy
- Summary: Request for Offer Pursuant to Art. 50 Paragraph 1 Letter B) of Legislative Decree 36/2023 Divided into 3 Lots for the Supply of the Drug Buprenorfina+Naloxone Cpr Sublingual
- ITT Ref No: 119310342
- Deadline: 21 May 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: EUR 62.67694
- Notice Type: Tender
- Document Ref. No.: 2025.0035201
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Request for offer pursuant to art. 50 paragraph 1 letter b) of Legislative Decree 36/2023 divided into 3 lots for the supply of the drug buprenorfina+naloxone cpr sublinguals various dosages
product categories: various medicines. - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINRequest for Offer Pursuant to Art. 50 Paragraph 1 Letter B) of Legislative Decree 36/2023 Divided into 3 Lots for the Supply of the Drug Buprenorfina+Naloxone Cpr Sublingual - Italy Tender
The ASP LARIAN LARIT, a Government sector organization in Italy, has announced a new tender for Request for Offer Pursuant to Art. 50 Paragraph 1 Letter B) of Legislative Decree 36/2023 Divided into 3 Lots for the Supply of the Drug Buprenorfina+Naloxone Cpr Sublingual. This tender is published on ItalyTenders under ITT Ref No: 119310342 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-21.
The estimated tender value is EUR 62.67694, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
